AUSTRALIAN DRUG DEVELOPMENT BLOG
The Latest Blogs from Agilex Biolabs

Author By Agilex BiolabsPosted on
Looking beyond the surface on the Complexity of Atopic Dermatitis Addressing inflammatory skin di...

Author By Agilex BiolabsPosted on
We took some time to sit down and talk with Jason so you could get to know him a bit better... My...

Author By Agilex BiolabsPosted on
We took some time to sit down and talk with Cameron so you could get to know him a bit better......

Author By Agilex BiolabsPosted on
We took some time to sit down and talk with Dr Sales so you could get to know him a bit better......

Author By Agilex BiolabsPosted on
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods...

Author By Agilex BiolabsPosted on
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug dis...

Author By Agilex BiolabsPosted on
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services....

Author By Agilex BiolabsPosted on
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The...

Author By Agilex BiolabsPosted on
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the...

Author By Agilex BiolabsPosted on
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bi...

Author By Agilex BiolabsPosted on
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.

Author By Agilex BiolabsPosted on
ddPCR technology provides an opportunity to streamline research and development processes, saving ti...